| Loperamide abuse associated with cardiac dysrhythmia and death W Eggleston, KH Clark, JM Marraffa Annals of Emergency Medicine 69 (1), 83-86, 2017 | 109 | 2017 |
| Kratom use and toxicities in the United States W Eggleston, R Stoppacher, K Suen, JM Marraffa, LS Nelson Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (7 …, 2019 | 95 | 2019 |
| Chemoprevention of prostate cancer by major dietary phytochemicals A Bommareddy, W Eggleston, S Prelewicz, A Antal, Z Witczak, DF Mccune, ... Anticancer research 33 (10), 4163-4174, 2013 | 73 | 2013 |
| Loperamide toxicokinetics: serum concentrations in the overdose setting W Eggleston, N Nacca, JM Marraffa Clinical Toxicology 53 (5), 495-496, 2015 | 61 | 2015 |
| Notes from the field: cardiac dysrhythmias after loperamide abuse—New York, 2008–2016 W Eggleston MMWR. Morbidity and mortality weekly report 65, 2016 | 42 | 2016 |
| The democratic forest W Eggleston, E Welty (No Title), 1989 | 41 | 1989 |
| William Eggleston's guide W Eggleston, J Szarkowski (No Title), 2002 | 35 | 2002 |
| Validation and Clinical Utility of the hERG IC50:Cmax Ratio to Determine the Risk of Drug‐Induced Torsades de Pointes: A Meta‐Analysis DF Lehmann, WD Eggleston, D Wang Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (3 …, 2018 | 33 | 2018 |
| Pediatric death after unintentional exposure to liquid nicotine for an electronic cigarette W Eggleston, N Nacca, CM Stork, JM Marraffa Clinical Toxicology 54 (9), 890-891, 2016 | 31 | 2016 |
| Hospital Observation Upon Reversal (HOUR) with naloxone: a prospective clinical prediction rule validation study BM Clemency, W Eggleston, EW Shaw, M Cheung, NS Pokoj, MA Manka, ... Academic Emergency Medicine 26 (1), 7-15, 2019 | 30 | 2019 |
| Loperamide toxicity: recommendations for patient monitoring and management W Eggleston, R Palmer, PA Dubé, S Thornton, A Stolbach, DP Calello, ... Clinical Toxicology 58 (5), 355-359, 2020 | 24 | 2020 |
| A randomized usability assessment of simulated naloxone administration by community members W Eggleston, C Podolak, RW Sullivan, L Pacelli, M Keenan, S Wojcik Addiction 113 (12), 2300-2304, 2018 | 22 | 2018 |
| Naloxone administration by untrained community members W Eggleston, V Calleo, M Kim, S Wojcik Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (1 …, 2020 | 20 | 2020 |
| Well, what is Photography?: A Lecture on Photography on the Occasion of the 10th Anniversary of Fotomuseum Winterthur U Stahel (No Title), 2003 | 14 | 2003 |
| Pharmacokinetics and pharmacodynamics of naloxone BM Clemency, W Eggleston, HA Lindstrom Academic Emergency Medicine 26 (10), 1203-1204, 2019 | 13 | 2019 |
| Ancient and modern W Eggleston, M Holborn (No Title), 1992 | 13 | 1992 |
| William Eggleston: democratic camera, photographs, and video, 1961-2008 E Sussman, T Weski, DM De Salvo, T Kukielski, S Booth, W Eggleston (No Title), 2008 | 11 | 2008 |
| Acute skeletal fluorosis in the setting of 1, 1-difluoroethane abuse A Ponce, JA Oakes, W Eggleston Clinical Toxicology 57 (5), 374-375, 2019 | 7 | 2019 |
| An Interview With William Eggleston C Hagen, W Eggleston Aperture, 40-77, 1989 | 7 | 1989 |
| Buprenorphine induced acute precipitated withdrawal in the setting of loperamide abuse W Eggleston, N Nacca, JM Marraffa CLINICAL TOXICOLOGY 53 (7), 662-662, 2015 | 6 | 2015 |
